Mark your calendars for Wednesday April 26th, 1-2 pm ET for this unique opportunity to interact with a leading researcher at the intersection of HIV and substance use. The NIDA HIV Research Program  (HRP) is pleased to announce the next presentation in its Seminar Series: A vicious cycle: The impact of inflammation and substance use on the control of HIV latency in microglia by Dr. Jonathan Karn, Reinberger, Professor & Chair of the Department of Molecular Biology & Microbiology at Case Western Reserve University School of Medicine. Dr. Karn has been studying transcriptional control in HIV since the mid-1980s. His current research focuses on the impact of substance use on the regulation of HIV transcription and latency in microglial cells.  Register here to receive your link.    

February 3, 2023 Save the Date The 2023 CTN Steering Committee meeting will be held at the Bethesda North Marriott Hotel & Conference Center (North Bethesda, MD) on April 24-26, 2023. More information on registration and logistics coming soon! Call for Posters Sharing of the results, experiences, techniques, and observations from performing our trials is a critical and exciting part of the CTN experience. To that end, CTN members are encouraged to submit posters for display at the 2023 CTN Annual Steering Committee Meeting Poster Session to be held on April 24, 2023. Poster submissions should be relatable to the CTN either directly (i.e. reporting on CTN studies, data, etc.) or indirectly (i.e. information that informs potential future CTN projects). As in previous years, we will consider new posters as well as posters that were presented at meetings over the past year. Event: CTN Annual Steering Committee Meeting Poster SessionVenue: Bethesda North Marriott Hotel & Conference Center (North Bethesda, MD)Date: Monday, April 24, 2023Time: 5:30 – 7:30 p.m. ET Guidelines:

February 15, 2023 | 11am-12:30pm PT | Register here! Digital therapeutics–software used to prevent, treat, or manage a medical disorder or disease–are redefining the future of healthcare. Digital therapeutics package an entire model of care that can be delivered with fidelity and in accordance with state-of-the-science best practices into a unified, seamless digital delivery system. Digital therapeutics have been particularly transformative in the field of substance use, mental health, and other behavioral health conditions and can markedly improve access to care, quality of care, and treatment outcomes, while reducing costs, for a wide array of audiences in diverse settings. In this presentation, Dr. Lisa A. Marsch (Dartmouth Center for Technology and Behavioral Health) will review the state of the science of digital therapeutics for behavioral health and timely opportunities to scale up access to these digital health tools via multiple paths to deployment around the world. Learning objectives 1.5 CME or CE credits available. See flyer for details on accreditation. Sponsored by the Northwest and Pacific Southwest ATTCs and the Western States Node of the NIDA CTN.

The goal of the National Institute of Drug Abuse (NIDA) Clinical Trials Network/Addiction Technology Transfer Center (ATTC) webinar series is to help scholars and clinicians in the addiction field stay abreast of cutting-edge science. This series is sponsored by the Western States Node of the CTN and the Pacific Northwest and Pacific Southwest ATTCs. The uptake in the use of telebehavioral services since the start of the Public Health Emergency (PHE) has been swift and is significantly transforming how behavioral health services are delivered. This is encouraging, as the research base for assessing and treating mental health conditions virtually is extensive and over 60 years old. However, for substance use disorders (SUDs), the research is less extensive and more recent. Mental health and SUD treatment services provided virtually are effective and serve as viable alternatives to in-person service delivery. Patients confirm high levels of satisfaction with telebehavioral health, while practitioners report more reluctance. Nonetheless, training has been shown to build practitioners’ skills, confidence, and competency. Using technology to facilitate clinical or recovery support sessions requires clinicians and peer support specialists to simulate real-time experiences (Hilty, 2002) that promote a therapeutic alliance (treatment) or connection (peer support). However, virtual service delivery requires some careful modification of the clinicians’ or peer support specialists’ skills to ensure engagement occurs and positive working relationships are developed. This webinar, presented by Nancy A. Roget, MS, MFT, LADC and Maryellen Evers, LCSW, CAADAC, CMFSW, will include a brief review of: telebehavioral health research and its efficacy, strategies…

The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) is hosting a virtual workshop titled “Target Trial Emulation in Observational Research and Translational Testing of Advanced Digital Health Tools for SUD Prevention and Treatment.” This workshop is scheduled for Thursday, September 29, 2022, from 10:30 a.m.– 4:30 p.m. ET. This workshop aims to introduce these trending approaches; assess their strengths, limitations, and potential; discuss feasible research questions; identify study priorities, and explore actionable strategies to address barriers and challenges for advancing substance use disorder (SUD) research.  The workshop consists of three subthemes with the following speakers. Learning SUD Evidence From Nationwide Data Sources Christopher Jones, Pharm.D., Dr.PH., M.P.H. Centers for Disease Control and Prevention Beth Han, M.D., Ph.D., M.P.H. National Institute on Drug Abuse, National Institutes of Health Julie Donohue, Ph.D. University of Pittsburgh Target Trial Emulation Using Real-World Healthcare Data Sara Lodi, Ph.D. Boston University Rolf Groenwold, Ph.D. Leiden University, Netherlands Joshua Wallach, Ph.D. M.S. Yale University Marc LaRochelle, M.D., M.P.H. Boston University Translational Testing of Clinical- and Community-Based Digital Health Systems Brandon Marshall, Ph.D. Brown University Rebecca Rossom, M.D., M.S. HealthPartners Jenny Lo-Ciganic, Ph.D., M.S.Pharm. University of Florida Walid Gellad, M.D., M.P.H. University of Pittsburgh Majid Afshar, M.D., MSCR University of Wisconsin-Madison Meeting Chair: Lisa Marsch, Ph.D. Dartmouth College